Application
LRRTM2 Antibody (C-term)(Cat. #AP18792b) western blot analysis in MDA-MB453 cell line lysates (35ug/lane).This demonstrates the LRRTM2 antibody detected the LRRTM2 protein (arrow).| Product Name | LRRTM2 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | LRRTM2; KIAA0416; LRRN2; Leucine-rich repeat transmembrane neuronal protein 2; Leucine-rich repeat neuronal 2 protein |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | KIAA0416 LRRN2 |
|---|---|
| Alternative Names | LRRTM2 KIAA0416 LRRN2 Leucine-rich repeat transmembrane neuronal protein 2 Leucine-rich repeat neuronal 2 protein |
| Molecular Weight(MW) | 59076 Da |
| Function | Involved in the development and maintenance of excitatory synapse in the vertebrate nervous system. Regulates surface expression of AMPA receptors and instructs the development of functional glutamate release sites. Acts as a ligand for the presynaptic receptors NRXN1-A and NRXN1-B (By similarity) |
| Tissue Specificity | Expressed in neuronal tissues. |
| Cellular Localization | Cell membrane; Single-pass type I membrane protein. Cell junction, synapse, postsynaptic cell membrane; Single-pass type I membrane protein (By similarity) Note=Localized to excitatory synapses (By similarity) |
| Entrez Gene | 26045 |
|---|---|
| Nucleotide Accession | NP_056379.1 |
Application
LRRTM2 Antibody (C-term)(Cat. #AP18792b) western blot analysis in MDA-MB453 cell line lysates (35ug/lane).This demonstrates the LRRTM2 antibody detected the LRRTM2 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
